Skip to content

Blueprint Medicines

blueprint

ABOUT US

Blueprint Medicines aims to make real the promise of precision therapy to improve and extend life for as many people with cancer and hematologic disorders as possible.


45 Sidney St
Cambridge, MA 02139
(617) 374-7580
blueprintmedicines.com

 

PRIMARY CONTACTS

Dean Petree
National Account Executive
(612) 669-9731
dpetree@blueprintmedicines.com

Rahul Kalathiya
Senior Medical Science Liaison
(859) 312-9053
rkalathiya@blueprintmedicines.com

PRODUCTS OR SERVICES


AYVAKIT® (avapritinib) is a prescription medicine used to treat adults with:

    • A certain type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumor (GIST) that cannot be treated with surgery or that has spread to other parts of the body (metastatic), and that is caused by certain abnormal platelet-derived growth factor receptor alpha (PDGFRA) genes. Your healthcare provider will perform a test to make sure that you have this abnormal PDGFRA gene and that AYVAKIT is right for you.

PRODUCTS OR SERVICES


 

    • Advanced systemic mastocytosis (AdvSM), including aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL). AYVAKIT is not recommended for the treatment of AdvSM in people with low platelet counts (less than 50 x 109/L).
    • Indolent systemic mastocytosis (ISM). AYVAKIT is not recommended in people with low platelet counts (less than 50 X 109/L).
Scroll To Top